The draft was announced by the Patent Protection Association of China on 5 June 2023 at the link below:

These do not only include names of Chinese courts, but also various terms of departments, titles, and parties involved in a trial.

Beijing Taide Pharmacy Limited Company (北京泰德制药有限公司) is challenging Pfizer. The drug at issue is Palbociclib capsule 125mg, for treating HR-positive and HER2-negative breast cancer (for personal reason, this is of big concern to myself).

Toby's Nov 2022 version of "The "Unofficial" CN Orange Book user guide for pharmaceutical patents".

Toby's June 2022 version of "Unofficial" CN Orange Book User Guide Available on IPO Law Journal, and at the link below

These stipulations were announced by the CN Supreme People's Court on 5 July 2021, one day after the announcement of the NMPA's measures. The announcement is as below...

From 2021 June, all subsidies for filing patent application should stop. From now on, all subsides for granting of patent should be reduced, and such patent grant subsidies should all stop by 2025.

Record compensation awarded by Beijing IP court in patent infringement case, with award of attorney fees.

CNIPA accepted the first two "important" infringement complaints. See the notice from the CNIPA below:

Announced on 20 Jul 2021, Deadline to submit comment is 10 Aug 2021 (Again, a very short deadline is set. I got the message behind)...

This is according to the announcement from the CNIPA below today (29 Oct 2021):

The equivalence of the US Orange Book in China, the "CN Orange Book" has been operating since 29 June 2021.

This article first provides explanations of the behavior of Chinese patent examiners (who are just normal humans after all), then provides an alternative approach if you are having difficulties in prosecuting...

Apparently the CNIPA has accepted more cases than the BJ IP Court. After checking with the CNIPA, the reason appears that the CNIPA does NOT require notarization and legalization of formality documents including the Power of Attorney and the business registration certificates.

Transition to the new CN patent law (comes into force on 1 June 2021) was published by the CNIPA yesterday.

The major texts of these drafts appear to be a set of rules from those of the Chinese courts, detailing the mechanism for accepting and the downstream handling of an infringement complaint.

CN patent linkage measures finalized and issued by NMPA.

The Opinion has many high level statements.

Suggestion to introduce use requirement in trademark applications in the reply to no. 1702 suggestion from the National People's Congress

The Cyberspace Administration of China announced Methods for Identifying Synthetic Content Generated by Artificial Intelligence on 7 March 2025.